Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, August 2002, p. 2671-2675, Vol. 46, No. 8
0066-4804/02/$04.00+0 DOI: 10.1128/AAC.46.8.2671-2675.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Incidence, Epidemiology, and Characteristics of Quinolone- Nonsusceptible Streptococcus pneumoniae in Croatia
Glenn A. Pankuch,1 Bülent Bozdogan,1 Kensuke Nagai,1 Arjana Tambi
-Andra
evi
,2 Slavko Schoenwald,2 Tera Tambi
,3 Smilja Kaleni
,4 Sanja Ple
ko,2 Nastja K. Tepe
,5 Zdenka Kotarski,6 Marina Payerl-Pal,7 and Peter C. Appelbaum1*
Department of Pathology, Hershey Medical Center, Hershey, Pennsylvania 17033,1
University Hospital of Infectious Diseases "Dr. F. Mihaljevic,",2
Croatian Academy of Medical Sciences,3
Zagreb Clinical Hospital Center,4
Sveti Duh General Hospital,5
University Hospital for Lung Diseases, Zagreb,6
Public Health Laboratory, Cakovec, Croatia7
Received 31 January 2002/
Returned for modification 30 March 2002/
Accepted 23 April 2002
Among 585 Streptococcus pneumoniae strains isolated in 22 Croatian hospitals 21 strains (3.6%) were quinolone nonsusceptible. MICs of all quinolones were high for seven strains tested with the same serotype (23F) and mutations in gyrA, parC, and parE. The remaining 14 strains were more heterogeneous and had mutations only in parC and/or parE, and the MICs of quinolones were lower for these strains.
* Corresponding author. Mailing address: Department of Pathology, Hershey Medical Center, P.O. Box 850, Hershey, PA 17033. Phone: (717) 531-5113. Fax: (717) 531-7953. E-mail:
pappelbaum{at}psu.edu.
Antimicrobial Agents and Chemotherapy, August 2002, p. 2671-2675, Vol. 46, No. 8
0066-4804/02/$04.00+0 DOI: 10.1128/AAC.46.8.2671-2675.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Yamamoto, K., Yanagihara, K., Sugahara, K., Imamura, Y., Seki, M., Izumikawa, K., Kakeya, H., Yamamoto, Y., Hirakata, Y., Kamihira, S., Kohno, S.
(2009). In Vitro Activity of Garenoxacin against Streptococcus pneumoniae Mutants with Characterized Resistance Mechanisms. Antimicrob. Agents Chemother.
53: 3572-3575
[Abstract]
[Full Text]
-
Wickman, P. A., Moland, E. S., Black, J. A., Thomson, K. S.
(2006). In Vitro Activity of DX-619, a Novel Des-Fluoro(6) Quinolone, against a Panel of Streptococcus pneumoniae Mutants with Characterized Resistance Mechanisms. Antimicrob. Agents Chemother.
50: 796-798
[Abstract]
[Full Text]
-
Kosowska, K., Hoellman, D. B., Lin, G., Clark, C., Credito, K., McGhee, P., Dewasse, B., Bozdogan, B., Shapiro, S., Appelbaum, P. C.
(2005). Antipneumococcal Activity of Ceftobiprole, a Novel Broad-Spectrum Cephalosporin. Antimicrob. Agents Chemother.
49: 1932-1942
[Abstract]
[Full Text]
-
Sadowy, E., Izdebski, R., Skoczynska, A., Gniadkowski, M., Hryniewicz, W.
(2005). High Genetic Diversity of Ciprofloxacin-Nonsusceptible Isolates of Streptococcus pneumoniae in Poland. Antimicrob. Agents Chemother.
49: 2126-2129
[Abstract]
[Full Text]
-
Davies, T. A., Goldschmidt, R., Pfleger, S., Loeloff, M., Bush, K., Sahm, D. F., Evangelista, A.
(2003). Cross-resistance, relatedness and allele analysis of fluoroquinolone-resistant US clinical isolates of Streptococcus pneumoniae (1998-2000). J Antimicrob Chemother
52: 168-175
[Abstract]
[Full Text]